Core Insights - Eli Lilly and Company (LLY) has launched its Employer Connect platform to address the access gap in U.S. obesity care, providing flexible solutions for employers and employees [1][2] Group 1: Employer Connect Platform - The Employer Connect platform aims to enhance employee access to obesity management medicines by facilitating coordination between employers and independent program administrators [1] - The platform offers various cost-sharing solutions to reduce out-of-pocket expenses for employees undergoing treatment for obesity [2] Group 2: Market Context - Eli Lilly develops and sells pharmaceutical products across multiple therapeutic areas, including oncology, diabetes, immunology, and neuroscience [3]